234 related articles for article (PubMed ID: 31048029)
1. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
Clasen J; Birkegård AC; Græsbøll K; Folkesson A
J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
[TBL] [Abstract][Full Text] [Related]
2. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
Tenover FC; Raney PM; Williams PP; Rasheed JK; Biddle JW; Oliver A; Fridkin SK; Jevitt L; McGowan JE;
J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
El Aila NA; Al Laham NA; Ayesh BM
BMC Infect Dis; 2023 Feb; 23(1):99. PubMed ID: 36803466
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
9. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
[TBL] [Abstract][Full Text] [Related]
10. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
[TBL] [Abstract][Full Text] [Related]
11. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula.
Medeiros AA; Crellin J
Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S49-55. PubMed ID: 9076836
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
[TBL] [Abstract][Full Text] [Related]
14. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
15. Total alkaloids from Sophora alopecuroides L. increase susceptibility of extended-spectrum β-lactamases producing Escherichia coli isolates to cefotaxime and ceftazidime.
Zhou XZ; Jia F; Liu XM; Yang C; Zhao L; Wang YJ
Chin J Integr Med; 2013 Dec; 19(12):945-52. PubMed ID: 22528755
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
Blahová J; Králiková K; Krcméry V; Schäfer V
J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
[TBL] [Abstract][Full Text] [Related]
18. Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.
Maina D; Revathi G; Kariuki S; Ozwara H
J Infect Dev Ctries; 2012 Jun; 6(6):470-7. PubMed ID: 22706188
[TBL] [Abstract][Full Text] [Related]
19. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Rajivgandhi G; Maruthupandy M; Manoharan N
Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
Chouchani C; Ben-Achour N; M'charek A; Belhadj O
C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
